Screening for Breast Cancer in Asymptomatic, Average-Risk Adult Females: A Guidance Statement From the American College of Physicians (Version 2)
Cet article présente une mise à jour des recommandations de l'"American College of Physicians" concernant le dépistage du cancer du sein chez les femmes adultes asymptomatiques présentant un risque moyen de développer la maladie
Description: The purpose of this updated guidance statement is to guide internal medicine physicians and other clinicians on screening for breast cancer in asymptomatic, average-risk adult females. Methods: The American College of Physicians updated its guidance statement on screening for breast cancer using high-quality clinical guidelines from national guideline developers around the world.
Guidance Statement 1: In asymptomatic, average-risk females aged 40 to 49 years, clinicians should discuss the female’s risk of breast cancer, values and preferences, and uncertainty around benefits and harms of screening for breast cancer. Following shared decision making, if a female in this population prefers to get screened for breast cancer, clinicians should then initiate screening mammography every 2 years (biennial).
Guidance Statement 2: In asymptomatic, average-risk females aged 50 to 74 years, clinicians should use biennial mammography for screening for breast cancer.
Guidance Statement 3: In asymptomatic, average-risk females aged 75 years or older or asymptomatic, average-risk females with a limited life expectancy, clinicians should discuss discontinuation of breast cancer screening based on shared decision making that includes the female’s risk of breast cancer, values and preferences, and uncertainty around benefits and harms of screening for breast cancer.
Guidance Statement 4: In asymptomatic, average-risk adult females with breast density of Breast Imaging Reporting and Data System (BI-RADS) category C or D, clinicians should consider using supplemental digital breast tomosynthesis based on benefits, harms, additional radiation exposure, availability, values and preferences, and cost.
Guidance Statement 5: In asymptomatic, average-risk adult females with breast density of BI-RADS category C or D, clinicians should not use supplemental magnetic resonance imaging or ultrasound.
Annals of Internal Medicine , article en libre accès, 2026